Johnson & Johnson - 49 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. The latest closing stock price for Johnson & Johnson as of October 18, 2019 is 127.70.
  • The all-time high Johnson & Johnson stock closing price was 148.14 on January 22, 2018.
  • The Johnson & Johnson 52-week high stock price is 148.99, which is 16.7% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 121.00, which is 5.2% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 135.54.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 134.4910 127.7500 144.2400 125.7200 127.7000 -1.05%
2018 133.0255 139.2300 148.1400 119.4000 129.0500 -7.64%
2017 129.7608 115.8400 143.6200 111.7600 139.7200 21.27%
2016 113.6073 100.4800 125.4000 95.7500 115.2100 12.16%
2015 99.7594 104.5200 106.3900 90.7300 102.7200 -1.77%
2014 100.8153 91.0300 109.0700 86.6200 104.5700 14.17%
2013 85.7595 70.8400 95.6300 70.7400 91.5900 30.66%
2012 66.9473 65.8800 72.5200 61.7800 70.1000 6.89%
2011 63.5544 62.8200 67.9200 57.6600 65.5800 6.03%
2010 62.1572 64.6800 66.0300 57.0200 61.8500 -3.97%
2009 57.7864 60.6500 64.9600 46.6000 64.4100 7.66%
2008 64.9140 65.9100 72.2200 55.3300 59.8300 -10.30%
2007 63.9777 66.4000 68.4000 59.7700 66.7000 1.03%
2006 62.2075 61.6300 69.1000 56.8000 66.0200 9.85%
2005 64.6922 62.9000 69.4000 60.0400 60.1000 -5.23%
2004 55.8880 51.6600 63.7600 49.5000 63.4200 22.76%
2003 52.6021 55.3300 58.6700 48.7300 51.6600 -3.82%
2002 57.6370 58.7000 65.4900 41.8500 53.7100 -9.12%
2001 51.9361 51.0000 60.9700 41.6250 59.1000 12.46%
2000 44.6343 46.0950 52.5500 34.2500 52.5500 12.71%
1999 47.0157 41.3450 53.0500 38.5000 46.6250 11.17%
1998 37.5132 32.5300 44.5000 32.0000 41.9400 27.32%
1997 29.8362 24.8750 33.4700 24.8750 32.9400 32.42%
1996 24.2629 21.0625 26.8750 21.0625 24.8750 16.37%
1995 17.2058 13.6250 22.8750 13.4375 21.3750 56.16%
1994 11.5482 11.3125 13.9375 9.1875 13.6875 21.99%
1993 10.4992 12.3750 12.3750 8.9075 11.2200 -11.13%
1992 12.3390 14.0313 14.5475 10.7825 12.6250 -11.79%
1991 11.2061 8.7500 14.4375 8.2025 14.3125 59.58%
1990 7.8557 7.4850 9.1725 6.5000 8.9688 20.83%
1989 6.2566 5.2263 7.4225 5.2263 7.4225 39.52%
1988 5.0606 4.8825 5.5075 4.3438 5.3200 13.68%
1987 5.3868 4.2113 6.5388 4.0313 4.6800 14.11%
1986 3.9821 3.2425 4.6175 2.9844 4.1013 24.71%
1985 2.7837 2.2263 3.4219 2.1950 3.2888 45.68%
1984 2.1431 2.5550 2.6488 1.7656 2.2575 -11.64%
1983 2.8541 3.0938 3.1950 2.4531 2.5550 -17.62%
1982 2.5529 2.2888 3.1875 2.0313 3.1013 33.68%
1981 2.1350 2.0808 2.4063 1.7813 2.3200 11.64%
1980 1.6533 1.5990 2.0833 1.3854 2.0781 25.87%
1979 1.5022 1.5469 1.6667 1.3490 1.6510 7.45%
1978 1.5989 1.5625 1.8490 1.3725 1.5365 -3.91%
1977 1.4657 1.6275 1.6275 1.3048 1.5990 -1.60%
1976 1.7987 1.8775 2.0025 1.5000 1.6250 -13.09%
1975 1.8534 1.7292 2.0625 1.5365 1.8698 10.97%
1974 2.0535 2.3281 2.4765 1.5650 1.6850 -28.27%
1973 2.4765 2.6771 2.7188 2.1771 2.3490 -13.60%
1972 2.4569 2.0365 2.7525 1.9765 2.7188 32.49%
1971 1.7733 1.1927 2.0600 1.1927 2.0521 72.81%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $359.375B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $250.381B 0.00
Merck (MRK) United States $214.559B 17.64
Pfizer (PFE) United States $201.662B 11.88
Novartis AG (NVS) Switzerland $199.914B 17.20
Novo Nordisk (NVO) Denmark $124.746B 22.04
Sanofi (SNY) France $116.442B 14.31
AstraZeneca (AZN) United Kingdom $115.787B 22.40
AbbVie (ABBV) United States $111.093B 8.90
GlaxoSmithKline (GSK) United Kingdom $105.929B 13.31
Eli Lilly (LLY) United States $104.711B 19.54
Bristol-Myers Squibb (BMY) United States $85.747B 12.16
Bayer (BAYRY) Germany $68.188B 9.93
H Lundbeck (HLUYY) Denmark $6.714B 9.69